MD, G., S, I., M, Y., SD, C., C, D., M, P., . . . Y, W. (2026). Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer. Proceedings of the National Academy of Sciences of the United States of America, 123(8), e2533449123. https://doi.org/10.1073/pnas.2533449123
Chicago Style (17th ed.) CitationMD, Galsky, et al. "Monitoring of Plasma and Urine Tumor-derived DNA to Inform Bladder-sparing Approaches for Patients with Muscle-invasive Bladder Cancer." Proceedings of the National Academy of Sciences of the United States of America 123, no. 8 (2026): e2533449123. https://doi.org/10.1073/pnas.2533449123.
MLA (9th ed.) CitationMD, Galsky, et al. "Monitoring of Plasma and Urine Tumor-derived DNA to Inform Bladder-sparing Approaches for Patients with Muscle-invasive Bladder Cancer." Proceedings of the National Academy of Sciences of the United States of America, vol. 123, no. 8, 2026, p. e2533449123, https://doi.org/10.1073/pnas.2533449123.
